Share your story with FINTEPLA
Aaron, living life with LGS
If you have a loved one who is living with Dravet syndrome or Lennox-Gastaut syndrome (LGS) and taking FINTEPLA, we want to hear from you. By sharing your story, you can help provide inspiration, hope, and encouragement to others going through similar experiences.
Hear about other families’ experiences with LGS and treatment with FINTEPLA.
Watch patient stories
You can also find information on LGS and FINTEPLA created for healthcare professionals by visiting FinteplaHCP.com.
Thank you for your interest in learning more about FINTEPLA!
FINTEPLA is only approved to treat the seizures associated with Dravet syndrome and LGS in patients 2 years of age and older. Please speak with your healthcare provider to discuss treatment options for your loved one.
Thank you for helping us provide more relevant information to you and the Dravet syndrome community!
Download a guide to help you plan for a conversation with your healthcare provider.
Get the guide
Thank you for helping us provide more relevant information to you and the Dravet syndrome community!
Hear about other families’ experiences with Dravet syndrome and treatment with FINTEPLA.
Watch patient stories1.Problems with the valves in the heart (valvular heart disease) and high blood pressure in the arteries of the lungs (pulmonary arterial hypertension) have been associated with fenfluramine, the active ingredient in FINTEPLA. Your healthcare provider will do a test called an echocardiogram to check your heart and to evaluate for high blood pressure in the arteries of the lungs before you start taking FINTEPLA, again every 6 months during treatment, and one time 3 to 6 months after you take your last dose of FINTEPLA.
Call your healthcare provider right away if you develop any of these signs and symptoms of heart or lung problems during treatment with FINTEPLA:
Because of the risk of heart valve problems (valvular heart disease) and high blood pressure in arteries of lungs (pulmonary arterial hypertension), FINTEPLA is only available through a restricted program called the FINTEPLA Risk Evaluation and Mitigation Strategy (REMS) Program. Before you or your child receives FINTEPLA, your healthcare provider or pharmacist will make sure you understand how to take FINTEPLA safely. If you have any questions about FINTEPLA, ask your healthcare provider, visit www.FinteplaREMS.com, or call 1-877-964-3649.
2. Decreased appetite and decreased weight. Decreased appetite and decreased weight are both serious and common side effects of FINTEPLA in people with Dravet syndrome (DS) or Lennox-Gastaut syndrome (LGS).
3. Sleepiness, sedation, and lack of energy (lethargy). These are both serious and common side effects of FINTEPLA in people with Dravet syndrome (DS) or Lennox-Gastaut syndrome (LGS). Taking FINTEPLA with central nervous system (CNS) depressants, including alcohol, may increase sleepiness. Do not drive, operate heavy machinery, or do other dangerous activities until you know how FINTEPLA affects you.
4. Like all other antiepileptic drugs, FINTEPLA may cause suicidal thoughts or actions in a very small number of people (about 1 in 500).
Suicidal thoughts or actions can be caused by things other than medicines. If you have suicidal thoughts or actions, your healthcare provider may check for other causes.
5. Do not stop taking FINTEPLA without first talking to your healthcare provider. Stopping a seizure medicine such as FINTEPLA can suddenly cause you to have seizures more often or seizures that do not stop (status epilepticus).
Call your healthcare provider between visits as needed, especially if you are worried about symptoms.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
Know the medicines you take. Keep a list of them to show your healthcare provider or pharmacist when you get a new medicine.
If you have any of these symptoms, call your healthcare provider right away.
These are not all the possible side effects of FINTEPLA. For more information, ask your healthcare provider or pharmacist. Tell your healthcare provider if you have any side effect that bothers you or that does not go away.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
Keep FINTEPLA and all medicines out of the reach of children.
Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use FINTEPLA for a condition for which it was not prescribed. Do not give FINTEPLA to other people, even if they have the same symptoms that you have. It may harm them.
Active ingredient: fenfluramine hydrochloride
Inactive ingredients:FINTEPLA contains no ingredient made from gluten-containing grain (wheat, barley, or rye) and contains not more than 0.1% of carbohydrates, which is from the cherry flavoring.
Please see full Prescribing Information, including Medication Guide, for additional Important Safety Information on FINTEPLA.
Meet Bethany and Kye
Meet Meagan and Austen
Meet Danielle and Johnny
Meet Lisa and Haley
Meet Jennifer and Aaron
FINTEPLA fits into your loved one’s treatment plan
Finding the right dose and managing side effects with Dravet syndrome
Finding the right dose and managing side effects with LGS
Meet the Mueller family
Risk Evaluation and Mitigation Strategy (REMS) Program
Tips for your loved one’s first echocardiogram
Your loved one’s safety comes first
Getting started with FINTEPLA
Financial support programs for access to FINTEPLA
Meet Chelsea and Miller
Meet Catrina and Aurora
Meet Christine, Sirena, and Trystyn
Meet the Norris family
Meet the Morales family
